today released by the metropolitan department of rospotrebnadzor, experts from st. petersburg , in turn. today they told how they go research on the universal flu and covid vaccine orfuvec. now the second stage is coming to an end, the intermediate results are positive, the drug works with a minimum number of side effects. the third phase of clinical trials is scheduled for next year. the peculiarity of the new remedy is that it protects against influenza for 5 years. this will allow you to refuse seasonal vaccination. also outside the game by explained. what is the peculiarity of the current wave and incidence. for two years, we and we are the global population of the earth and not only russians. we practically never met. e with pathogens of other orvins, as a result, natural immunity has not been formed in us, so the expectation of, let's say, the scientific community. those who are involved, uh, in forecasting and in supervision, were that this year we will hit all the peaks in incidence, because we turned out to be vulnerable, it is rather difficult to build for